New long-term data of the investigational therapy icotrokinra show that it is able to achieve site-specific clear or almost clear skin in patients with plaque psoriasis, according to results of the ...

Targeting immunosuppressive myeloid cells via implant-mediated slow release of small molecules to prevent glioblastoma recurrence. Abstract. Glioblastoma is a highly aggressive br ...

Whole Wheat Bread Whole wheat bread might seem like a healthy choice, but it can actually be mildly inflammatory for many ...

Patients with PsA who are treated with CTT are not at a greater risk for serious or opportunistic infections compared with standard therapy.

Forlong Biotechology inks agreement with Shanghai Henlius Biotech to develop cancer immunotherapy: Shanghai Friday, October 24, 2025, 17:00 Hrs [IST] Forlong Biotechnology, a clin ...

US healthcare giant Johnson & Johnson today announced that the European Commission (EC) has approved the expansion for the ...

EBGLYSS (lebrikizumab-lbkz) sustained similar levels of skin clearance when administered as a single injection of 250 mg once ...

Machine learning models accurately predict which psoriatic and axial spondyloarthritis patients will respond to treatment, ...

San Diego-based inflammatory diseases specialist Ventyx Biosciences announced positive results from its Phase II study of ...

A single bout of resistance training (RT) as well as high-intensity interval training (HIIT) can contribute to a lower risk of recurrence of breast cancer among the survivors, ...

In areas of high impact, 72% of patients with scalp psoriasis and 85% with genital psoriasis treated with icotrokinra achieved site-specific clear or ...

Positive within-person associations seen between general fatigue and TNF-α, sTNF-RII, IL-6; and between physical fatigue and TNF-α, sTNF-RII, CRP.